AAAAAA
Results: 1-25/33
Authors:
Temelkova-Kurktschiev, T
Fischer, S
Koehler, C
Mennicken, G
Henkel, E
Hanefeld, M
Citation: T. Temelkova-kurktschiev et al., Intima-media thickness in healthy subjects without risk factors for atherosclerosis, DEUT MED WO, 126(8), 2001, pp. 193-197
Authors:
Hanefeld, M
Citation: M. Hanefeld, Clinical rationale for rosuvastatin, a potent new HMG-CoA reductase inhibitor, INT J CL PR, 55(6), 2001, pp. 399-405
Authors:
Hanefeld, M
Citation: M. Hanefeld, Pharmacokinetics and clinical efficacy of pioglitazone, INT J CL PR, 2001, pp. 19-25
Authors:
Hanefeld, M
Belcher, G
Citation: M. Hanefeld et G. Belcher, Safety profile of pioglitazone, INT J CL PR, 2001, pp. 27-31
Authors:
Klemm, T
Neumann, S
Trulzsch, B
Pistrosch, F
Hanefeld, M
Paschke, R
Citation: T. Klemm et al., Search for mitochondrial DNA, mutation ate position 3243 in German patients with a positive family history of maternal diabetes mellitus, EXP CL E D, 109(5), 2001, pp. 283-287
Authors:
Temelkova-Kurktschiev, T
Henkel, E
Kohler, C
Hanefeld, M
Citation: T. Temelkova-kurktschiev et al., Relationship of the intima-media-thickness (IMT) and plaques of the carotid arteries and the arteries of the lower limbs to manifest macrovascular diseases: The RIAD study, PERFUSION, 14(8), 2001, pp. 305
Authors:
Hanefeld, M
Abletshauser, C
Citation: M. Hanefeld et C. Abletshauser, Effect of the angiotensin II receptor antagonist valsartan on lipid profile and glucose metabolism in patients with hypertension, J INT MED R, 29(4), 2001, pp. 270-279
Authors:
Standl, E
Schernthaner, G
Rybka, J
Hanefeld, M
Raptis, SA
Naditch, L
Citation: E. Standl et al., Improved glycaemic control with miglitol in inadequately-controlled type 2diabetics, DIABET RE C, 51(3), 2001, pp. 205-213
Light-to-moderate alcohol consumption, risk factor profile and early atherosclerosis: the RIAD Study
Authors:
Temelkova-Kurktschiev, T
Henkel, E
Koehler, C
Hanefeld, M
Citation: T. Temelkova-kurktschiev et al., Light-to-moderate alcohol consumption, risk factor profile and early atherosclerosis: the RIAD Study, ATHEROSCLER, 156(1), 2001, pp. 239-240
Authors:
Hanefeld, M
Citation: M. Hanefeld, Post-prandial hyperglycaemia and vascular disease, INT J CL PR, 2000, pp. 13-18
Authors:
Temelkova-Kurktschiev, T
Henkel, E
Schaper, F
Koehler, C
Siegert, G
Hanefeld, M
Citation: T. Temelkova-kurktschiev et al., Prevalence and atherosclerosis risk in different types of non-diabetic hyperglycemia. Is mild hyperglycemia an underestimated evil?, EXP CL E D, 108(2), 2000, pp. 93-99
Authors:
Hanefeld, M
Goke, B
Citation: M. Hanefeld et B. Goke, Combining pioglitazone with a sulphonylurea or metformin in the managementof type 2 diabetes, EXP CL E D, 108, 2000, pp. S256-S266
Authors:
Pixa, A
Pietzsch, J
Julius, U
Menschikowski, M
Hanefeld, M
Citation: A. Pixa et al., Impaired glucose tolerance (IGT) is not associated with disturbed homocysteine metabolism, AMINO ACIDS, 18(3), 2000, pp. 289-298
Authors:
Hanefeld, M
Koehler, C
Henkel, E
Fuecker, K
Schaper, F
Temelkova-Kurktschiev, T
Citation: M. Hanefeld et al., Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD Study, DIABET MED, 17(12), 2000, pp. 835-840
Authors:
Hanefeld, M
Bouter, KP
Dickinson, S
Guitard, C
Citation: M. Hanefeld et al., Rapid and short-acting mealtime insulin secretion with nateglinide controls both prandial and mean glycemia, DIABET CARE, 23(2), 2000, pp. 202-207
Authors:
Temelkova-Kurktschiev, TS
Koehler, C
Henkel, E
Leonhardt, W
Fuecker, K
Hanefeld, M
Citation: Ts. Temelkova-kurktschiev et al., Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA(1c) level, DIABET CARE, 23(12), 2000, pp. 1830-1834
Authors:
Noack, B
Jachmann, I
Roscher, S
Sieber, L
Kopprasch, S
Luck, C
Hanefeld, M
Hoffmann, T
Citation: B. Noack et al., Metabolic diseases and their possible link to risk indicators of periodontitis, J PERIODONT, 71(6), 2000, pp. 898-903
Authors:
Hanefeld, M
Citation: M. Hanefeld, Postprandial state abnormalities: Neglected cardiovascular risk factors indiabetes - Satellite Symposium, 35th Annual Meeting of the European Association for the Study of Diabetes 28 September-2 October 1999, Brussels - Editor's introduction, EUR J CL IN, 30, 2000, pp. 1-2
Authors:
Wildbrett, J
Nagel, M
Theissig, F
Gaertner, HJ
Gromeier, S
Fischer, S
Hanefeld, M
Citation: J. Wildbrett et al., Unusual picture of an insulinoma in type 2 diabetes mellitus with severe obesity, DEUT MED WO, 124(9), 1999, pp. 248-252
Authors:
Kohler, C
Temelkova-Kurktschiev, T
Schaper, F
Fucker, K
Hanefeld, M
Citation: C. Kohler et al., Prevalence of newly diagnosed type 2 diabetes, impaired glucose tolerance and abnormal fasting glucose in an at-risk population: data from the RIAD study using new diagnostic criteria, DEUT MED WO, 124(37), 1999, pp. 1057-1061
Authors:
Temelkova-Kurktschiev, T
Siegert, G
Koehler, C
Henkel, E
Hanefeld, M
Citation: T. Temelkova-kurktschiev et al., Impaired fibrinolysis and early atherosclerosis in impaired glucose tolerance and newly detected type 2 diabetes, FIBRINOL PR, 13, 1999, pp. 11-15
Authors:
Scheuch, K
Hanefeld, M
Grassler, J
Seibt, R
Naumann, HJ
Citation: K. Scheuch et al., Hypertriglyceridaemia in mild hypertension: impact on cardiovascular and hormonal reactivity under different stress tests, J HUM HYPER, 13(8), 1999, pp. 533-539
Authors:
Leonhardt, W
Horn, R
Brabant, G
Breidert, M
Temelkova-Kurktschiev, T
Fucker, K
Hanefeld, M
Citation: W. Leonhardt et al., Relation of free and specifically bound leptin to insulin secretion in patients with impaired glucose tolerance (IGT), EXP CL E D, 107(1), 1999, pp. 46-52
Authors:
Gehrisch, S
Kostka, H
Tiebel, M
Patzak, A
Paetzold, A
Julius, U
Schroeder, HE
Hanefeld, M
Jaross, W
Citation: S. Gehrisch et al., Mutations of the human hepatic lipase gene in patients with combined hypertriglyceridemia/hyperalphalipoproteinemia and in patients with familial combined hyperlipidemia, J MOL MED-J, 77(10), 1999, pp. 728-734
Authors:
Hanefeld, M
Temelkova-Kurktschiev, T
Schaper, F
Henkel, E
Siegert, G
Koehler, C
Citation: M. Hanefeld et al., Impaired fasting glucose is not a risk factor for atherosclerosis, DIABET MED, 16(3), 1999, pp. 212-218